Clinical Research in Latin America
Recent Trials
Clinical Trials in:
Argentina,
Brazil,
Colombia &
Mexico
With Headquarters in Monterrey, Mexico and 5 local offices across Latin America, Cohortias offers a customized service from protocol writing all the way to data management.
Our infrastructure in Latin America is composed of Qualified Sites, Investigators, KOLs, Physicians and Regulatory Experts, that all reside in each one of the countries were Cohortias operates.
This locally-based resources allows us to offer lower costs and shorter timelines when it comes to regulatory approvals and patient recruitment.
See below our track record of recent Clinical Trials conducted in Argentina, Brazil, Colombia and Mexico.
With Global Headquarters in Mexico, we offer first-hand knowledge of the region.
This allows us to guarantee better results when compared to any other global CRO
Discover our Region
Why Latin America?
Several factors contribute to Latin America being a region of choice to conduct your clinical trials:
Patient Access
Over 600 million inhabitants and 80% urban population. Large metropolitan areas provide patient concentrations for stronger enrollment.
Compliance & Retention
Strong patient-doctor relationship built upon the health infrastructure of each country, this is why drop-out rates in the region are one-third those of US and EU.
Lack of Language Barrier
Only 2 languages - Spanish and Portuguese. With many english bilingual (English is predominant in the region).
disease prevalence
Cardiovascular, arthritis, cancer, and infectious diseases are as prevalent as in the United States.
Play Video
Transforming Lives Through Clinical Research
Martijn Wallert
CEO & Co-Founder
Request a consultation
Let us guide through the Clinical Research landscape of Latin America
